glp-1 for obesity Agonists In Myths & Facts: GLP-1 Drugs

Understanding Wegovy and Zepbound Both Wegovy and Zepbound are FDA approved obesity medication options designed to help adults manage weight more effectively

The metabolic syndrome in Australia: prevalence using four definitions

A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs MyPhenome could help identify patients for whom the drugs are worth the cost and potential side effects

Diuretics increase urine output, which should theoretically reduce UTI risk by flushing bacteria

Many patients hear that they need a certain BMI to qualify for GLP-1 weight loss treatment, but they are not always sure how BMI is actually calculated